Sanofi Sues FDA, Claiming Agency Exceeded Its Authority In Approving Enoxaparin

Company claims the agency approved the generic although the innovator drug had not been fully characterized, but odds are against a Sanofi win in court.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet